Brown Brothers Harriman & Co’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,952
| Closed | -$346K | – | 1280 |
|
|
2020
Q1 | $346K | Sell |
1,952
-82
| -4% | -$15.4K | ﹤0.01% | 279 |
|
|
2019
Q4 | $389K | Sell |
2,034
-975
| -32% | -$176K | ﹤0.01% | 345 |
|
|
2019
Q3 | $506K | Buy |
3,009
+227
| +8% | +$37K | ﹤0.01% | 290 |
|
|
2019
Q2 | $466K | Buy |
2,782
+41
| +1% | +$5.68K | ﹤0.01% | 281 |
|
|
2019
Q1 | $401K | Buy |
2,741
+873
| +47% | +$127K | ﹤0.01% | 286 |
|
|
2018
Q4 | $250K | Buy |
1,868
+47
| +3% | +$7.71K | ﹤0.01% | 317 |
|
|
2018
Q3 | $347K | Buy |
1,821
+350
| +24% | +$64.3K | ﹤0.01% | 292 |
|
|
2018
Q2 | $245K | Sell |
1,471
-64
| -4% | -$10.3K | ﹤0.01% | 316 |
|
|
2018
Q1 | $258K | Sell |
1,535
-73
| -5% | -$12.2K | ﹤0.01% | 301 |
|
|
2017
Q4 | $263K | Buy |
1,608
+140
| +10% | +$25.1K | ﹤0.01% | 306 |
|
|
2017
Q3 | $301K | Hold |
1,468
| – | – | ﹤0.01% | 275 |
|
|
2017
Q2 | $357K | Hold |
1,468
| – | – | ﹤0.01% | 260 |
|
|
2017
Q1 | $351K | Sell |
1,468
-236
| -14% | -$55K | ﹤0.01% | 262 |
|
|
2016
Q4 | $358K | Sell |
1,704
-5,951
| -78% | -$1.23M | ﹤0.01% | 243 |
|
|
2016
Q3 | $1.76M | Sell |
7,655
-3,764
| -33% | -$920K | 0.01% | 145 |
|
|
2016
Q2 | $2.64M | Buy |
11,419
+452
| +4% | +$104K | 0.01% | 128 |
|
|
2016
Q1 | $2.94M | Buy |
10,967
+854
| +8% | +$244K | 0.02% | 124 |
|
|
2015
Q4 | $3.16M | Sell |
10,113
-823
| -8% | -$245K | 0.02% | 118 |
|
|
2015
Q3 | $2.97M | Buy |
10,936
+2,354
| +27% | +$723K | 0.02% | 121 |
|
|
2015
Q2 | $2.6M | Sell |
8,582
-1
| -0% | -$298 | 0.01% | 133 |
|
|
2015
Q1 | $2.56M | Buy |
8,583
+8,167
| +1,963% | +$2.33M | 0.01% | 130 |
|
|
2014
Q4 | $107K | Hold |
416
| – | – | ﹤0.01% | 432 |
|
|
2014
Q3 | $100K | Buy |
416
+16
| +4% | +$3.58K | ﹤0.01% | 438 |
|
|
2014
Q2 | $88K | Hold |
400
| – | – | ﹤0.01% | 451 |
|
|
2014
Q1 | $82K | Hold |
400
| – | – | ﹤0.01% | 438 |
|
|
2013
Q4 | $67K | Hold |
400
| – | – | ﹤0.01% | 424 |
|
|
2013
Q3 | $58K | Hold |
400
| – | – | ﹤0.01% | 451 |
|
|
2013
Q2 | $50K | Buy |
+400
| New | +$45.3K | ﹤0.01% | 535 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Brown Brothers Harriman & Co's AGN Position: Q2 2020 in Review
Brown Brothers Harriman & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,952 shares — an estimated $346K sold.
Brown Brothers Harriman & Co first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $3.16M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Brown Brothers Harriman & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Brown Brothers Harriman & Co sold 1,952 Allergan plc shares in Q2 2020, an estimated $346K.
- Brown Brothers Harriman & Co first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Brown Brothers Harriman & Co's Allergan plc position peaked at $3.16M in Q4 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2020, filed 13 Aug 2020.